BTIG Reiterates Sell Rating on Ginkgo Bioworks Holdings Inc (DNA)

September 4, 2026 6:12 AM EDT Send to a Friend
BTIG analyst Mark A. Massaro reiterated a Sell rating and $5.00 price target on Ginkgo Bioworks Holdings Inc (NYSE: DNA).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login